Loading companies…
C
CroíValve
Ireland · Healthtech
Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $27M | BGF — Role not disclosedEuropean Innovation Council (EIC) — Role not disclosedMedTech Syndicate — Role not disclosed |
Investors
BGFSeries BEuropean Innovation Council (EIC)Series BMedTech SyndicateSeries BCoverage
Jun 23, 2026CroíValve · Series BSimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
Blue Health IntelligenceBlue Health Intelligence combines a one-hour health assessment with doctor-led interpretation and a digital plan for preventive care.€3.4M · €3.4 million growth capital